Article

ARVO announces 2023 recipient of Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists

The Genentech Award is intended to provide early-career underrepresented minority investigators with an opportunity to explore novel and innovative research project ideas.

Winners receive a two-year grant totaling $100,000 to support research and personnel costs for establishing an independent vision research program.

Winners receive a two-year grant totaling $100,000 to support research and personnel costs for establishing an independent vision research program.

The Association for Research in Vision and Ophthalmology (ARVO) announced the recipient of its Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists recently.

According to an ARVO news release, Edmund Arthur, OD, PhD, will receive a two-year grant totaling $100,000 to support research and personnel costs for establishing an independent vision research program.

Arthur, an optometrist and a vision scientist, is currently an assistant professor of optometry at the University of Alabama at Birmingham. In the ARVO release, it is stated Arthur will use this grant to investigate a novel retinal vascular biomarker for early diabetic retinopathy (DR) detection and disease monitoring known as the peripheral capillary free zones.

"This award provides critical support for my research career," Arthur said in the ARVO release. "The data from this two-year pilot study will inform several future research projects in diabetic retinopathy (DR) and diabetic macular edema (DME) in my lab." In the release, Arthur went into further detail on the study stating, "This will be a three-year cross-sectional study aimed at developing a biological variable model that includes ethnicity, HbA1c, age, and sex in screening for individuals at risk of worse diabetes associated retinal neurodegeneration in underserved populations."

According to ARVO, as part of the award, Arthur will also be matched with a mentor outside of his home institution to provide support for his career advancement.

ARVO is the largest eye and vision research organization in the world with members from approximately 10,000 eye and vision researchers from over 75 countries. For more information on the ARVO Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists, visit ARVO’s website.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.